Both PI-103 and 17-AAG when combined with TRAIL caused a decrease in the levels of IKKα and its phosphorylated form in TRAIL-resistant RKO cancer cells; expression of the caspase inhibitor protein XIAP was also decreased following both co-treatments (Fig. 5B). The gene discussed is CHUK; the disease is cancer.